Erratum: Association of Pyoderma Gangrenosum, Acne, and Suppurative Hidradenitis (PASH) Shares Genetic and Cytokine Profiles with Other Autoinflammatory Diseases (Medicine and Science in Sports and Exercise (2014) 93:27 (e187) DOI: 10.1097/MD.0000000000000187);Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases

Medicine (United States)

Volumn 93, Issue 27, 2014, Pages

  Marzano, Angelo V ^a   Ceccherini, Isabella ^b   Gattorno, Marco ^b   Fanoni, Daniele ^a   Caroli, Francesco ^b   Rusmini, Marta ^b   Grossi, Alice ^b   De Simone, Clara ^c   Borghi, Orietta M ^a   Meroni, Pier Luigi ^a   Crosti, Carlo ^a   Cugno, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CD40 LIGAND; CXCL1 CHEMOKINE; CXCL16 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FAS LIGAND; GENOMIC DNA; INFLIXIMAB; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 8; L SELECTIN; RANTES; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; CD40 ANTIGEN; CYTOKINE; FAS ANTIGEN; MATRIX METALLOPROTEINASE; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADOLESCENT; ADULT; ARTICLE; CERVICOBRACHIAL NEURALGIA; CLINICAL ARTICLE; CLINICAL FEATURE; CROHN DISEASE; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; OBESITY; OBSERVATIONAL STUDY; PAPA SYNDROME; PAPULOVESICULAR RASH; POLYARTHRITIS; PROTEIN EXPRESSION; SKIN ABSCESS; SKIN FISTULA; SKIN ULCER; SPONDYLARTHRITIS; ACNE VULGARIS; AUTOIMMUNE DISEASE; BLOOD; COMPLICATION; GENETICS; METABOLISM; MIDDLE AGED; PYODERMA GANGRENOSUM; SKIN; SUPPURATIVE HIDRADENITIS; YOUNG ADULT;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTIGENS, CD40; ANTIGENS, CD95; AUTOIMMUNE DISEASES; CYTOKINES; E-SELECTIN; FEMALE; HIDRADENITIS SUPPURATIVA; HUMANS; L-SELECTIN; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; PYODERMA GANGRENOSUM; SIALIC ACID BINDING IMMUNOGLOBULIN-LIKE LECTINS; SKIN; TISSUE INHIBITOR OF METALLOPROTEINASES; YOUNG ADULT;

EID: 84919327524     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/01.MD.0000462395.68470.98     Document Type: Erratum

References (45)

1. Braun-Falco M, Kovnerystyy O, Lohse P, et al. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)-a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol. 2012; 66: 409-415.
2. Marzano AV, Ishak RS, Colombo A, et al. Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome following bowel bypass surgery. Dermatology. 2012; 225: 215-219.
3. Aksentijevich I, Kastner DL. Genetics of monogenic autoinflammatory diseases: past successes, future challenges. Nat Rev Rheumatol. 2011; 7: 469-478.
4. Kastner DL, Aksentijevich I, Goldbach-Mansky R. Autoinflammatory disease reloaded: a clinical perspective. Cell. 2010; 140: 784-790.
5. Doria A, Zen M, Bettio S, et al. Autoinflammation and autoimmunity: bridging the divide. Autoimmun Rev. 2012; 12: 22-30.
6. Almeida de Jesus A, Goldbach-Mansky R. Monogenic autoinflammatory diseases: concept and clinical manifestations. Clin Immunol. 2013; 147: 155-174.
7. Marzano AV, Ishak RS, Saibeni S, et al. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol. 2013; 45: 202-210.
8. Wollina U, Haroske G. Pyoderma gangraenosum. Curr Opin Rheumatol. 2011; 23: 50-56.
9. Kistowska M, Gehrke S, Jankovic D, et al. IL-1b drives inflammatory responses to Propionibacterium acnes in vitro and in vivo. J Invest Dermatol. 2014; 134: 677-685.
10. Qin M, Pirouz A, Kim MH, et al. Propionibacterium acnes induces IL-1b secretion via the NLRP3 inflammasome in human monocytes. J Invest Dermatol. 2014; 134: 381-388.
11. Li ZJ, Choi DK, Sohn KC, et al. Propionibacterium acnes activates the NLRP3 inflammasome in human sebocytes. J Invest Dermatol. 2014; 134: 2747-2756.
12. Wise CA, Gillum JD, Seidman CE, et al. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet. 2002; 11: 961-969.
13. Dinarello CA. A clinical perspective of IL-1b as the gatekeeper of inflammation. Eur J Immunol. 2011; 41: 1203-1217.
14. André MF, Aumaître O, Grateau G, et al. Longest form of CCTG microsatellite repeat in the promoter of the CD2BP1/PSTPIP1 gene is associated with aseptic abscesses and with Crohn disease in French patients. Dig Dis Sci. 2010; 55: 1681-1688.
15. André MF, Piette JC, Kémény JL, et al. Aseptic abscesses: a study of 30 patients with or without inflammatory bowel disease and review of the literature. Medicine (Baltimore). 2007; 86: 145-161.
16. Marzano AV, Trevisan V, Gattorno M, et al. Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene. JAMA Dermatol. 2013; 149: 762-764.
17. Marzano AV, Trevisan V, Lazzari R, et al. Pyoderma gangrenosum: study of 21 patients and proposal of a "clinicotherapeutic" classification. J Dermatolog Treat. 2011; 22: 254-260.
18. Langan SM, Groves RW, Card TR, et al. Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol. 2012; 132: 2166-2170.
19. Chamot AM, Benhamou CL, Kahn MF, et al. Acne-pustulosishyperostosis- osteitis syndrome. Results of a national survey. 85 cases. Rev Rhum Mal Osteoartic. 1987; 54: 187-196.
20. Chen W, Obermayer-Pietsch B, Hong JB, et al. Acne-associated syndromes: models for better understanding of acne pathogenesis. J Eur Acad Dermatol Venereol. 2011; 25: 637-646.
21. Wallach D, Vignon-Pennamen MD. From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research. J Am Acad Dermatol. 2006; 55: 1066-1071.
22. Hsiao JL, Antaya RJ, Berger T, et al. Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review. Arch Dermatol. 2010; 146: 1265-1270.
23. Ah-Weng A, Langtry JA, Velangi S, et al. Pyoderma gangrenosum associated with hidradenitis suppurativa. Clin Exp Dermatol. 2005; 30: 669-671.
24. Rosner IA, Richter DE, Huettner TL, et al. Spondyloarthropathy associated with hidradenitis suppurative and acne conglobata. Ann Intern Med. 1982; 97: 520-525.
25. Shenefelt PD. Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen. Cutis. 1996; 57: 315-319.
26. Koshelev MV, Garrison PA, Wright TS. Concurrent hidradenitis suppurativa, inflammatory acne, dissecting cellulitis of the scalp, and pyoderma gangrenosum in a 16-year-old boy. Pediatr Dermatol. 2014; 31: e20-e21.
27. Newman B, Cescon D, Domenchini A, et al. CD2BP1 and CARD15 mutations are not associated with pyoderma gangrenosum in patients with inflammatory bowel disease. J Invest Dermatol. 2004; 122: 1054-1056.
28. Nesterovitch AB, Hoffman MD, Simon M, et al. Mutations in the PSTPIP1 gene and aberrant splicing variants in patients with pyoderma gangrenosum. Clin Exp Dermatol. 2011; 36: 889-895.
29. Melnik BC, Plewig G. Impaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology. Exp Dermatol. 2013; 22: 172-177.
30. Demidowich AP, Freeman AF, Kuhns DB, et al. Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne). Arthritis Rheum. 2012; 64: 2022-2027.
31. Guenova E, Teske A, Fehrenbacher B, et al. Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab. Arch Dermatol. 2011; 147: 1203-1205.
32. Marzano AV, Fanoni D, Antiga E, et al. Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome. Clin Exp Immunol. 2014; 178: 48-56.
33. Dréno B, Khammari A, Brocard A, et al. Hidradenitis suppurativa: the role of deficient cutaneous innate immunity. Arch Dermatol. 2012; 148: 182-186.
34. Hofmann SC, Saborowski V, Lange S, et al. Expression of innate defense antimicrobial peptides in hidradenitis suppurativa. J Am Acad Dermatol. 2012; 66: 966-974.
35. Mozeika E, Pilmane M, Nürnberg BM, et al. Tumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativa. Acta Derm Venereol. 2013; 93: 301-304.
36. Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature. 2007; 447: 661-678.
37. Hampe J, Grebe J, Nikolaus S, et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet. 2002; 359: 1661-1665.
38. Verma D, Särndahl E, Andersson H, et al. The Q705K polymorphism in NLRP3 is a gain-of-function alteration leading to excessive interleukin-1b and IL-18 production. PLoS One. 2012; 7: e34977.
39. Shinar Y, Obici L, Aksentijevich I, et al. Guidelines for the genetic diagnosis of hereditary recurrent fevers. Ann Rheum Dis. 2012; 71: 1599-1605.
40. Marzano AV, Cugno M, Trevisan V, et al. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol. 2010; 162: 100-107.
41. Pène J, Chevalier S, Preisser L, et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol. 2008; 180: 7423-7430.
42. Agarwal S, Misra R, Aggarwal A. Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. J Rheumatol. 2008; 35: 515-519.
43. Pillai S, Netravali IA, Cariappa A, et al. Siglecs and immune regulation. Annu Rev Immunol. 2012; 30: 357-392.
44. Wehrli P, Viard I, Bullani R, et al. Death receptors in cutaneous biology and disease. J Invest Dermatol. 2000; 115: 141-148.
45. Brugnolo F, Annunziato F, Sampognaro S, et al. Highly Th2-skewed cytokine profile of beta-lactam-specific T cells from nonatopic subjects with adverse drug reactions. J Immunol. 1999; 163: 1053-1059.